ArticleIndian journal of thoracic and cardiovascular surgery2025
Total endoscopic resection of left atrial myxoma.
Article in Indian journal of thoracic and cardiovascular surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Giant atrial myxoma.Journal of ultrasound · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Myxoma is a rare benign cardiac tumor occurring mostly in the left atrium. Surgical removal of the lesion is indicated to avoid intracardiac obstruction and systemic embolism. We performed surgical removal of left atrial myxoma by total endoscopic surgery without robotic assistance in 40 patients. In this technique, surgical instruments are inserted through four incisions with trocars < 1.5 cm in size. The mean cardiopulmonary bypass and aortic cross-clamp times were 141.3 ± 33.7 and 74.8 ± 28.3 min, respectively. There were no cases of death or conversion to median sternotomy, and the postoperative hospital stay was 7.2 ± 5.0 days. No cases of tumor recurrence or septal leakage occurred over follow-up periods of 3-61 months. Our technique was shown to be both feasible and safe for the removal of left atrial myxoma.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.